Daily metformin use in the month before pregnancy is associated with more than 70% reduction in risk for hyperemesis ...

Metformin use may enhance progression-free survival (PFS) in patients receiving first-line systemic therapy for patients with ...

In the early 2000s a clinical trial showed that lifestyle modification was better than metformin at preventing Type 2 ...

The addition of anagliptin to insulin and metformin therapy may improve glycemic control in patients with type 2 diabetes while maintaining an acceptable safety profile.

Adopting a healthier lifestyle is more effective than using the anti-diabetes drug metformin, with the benefits persisting ...

Rapamycin may help prolong life as much as some dietary interventions, according to animal research. These findings, though, ...

A new study published in the American Journal of Obstetrics and Gynaecology revealed that for women with polycystic ovary ...

In the early 2000s the U.S. Diabetes Prevention Program (DPP), a large randomized clinical trial, showed that intensive lifestyle modification was ...

The active ingredient in Ozempic was associated with a reduced risk of Alzheimer's disease-related dementia among diabetes ...

GLP-1RA use initially lowered delirium risk but eventually heightened delirium risk after 5 years among patients with type 2 diabetes.

Rapamycin may match the benefits of eating less. Scientists are now exploring its potential to support healthy aging. The ...

“Metformin is a widely used, first-line medication for treating type 2 diabetes.It belongs to a class of drugs called biguanides,” says Hans J. Schmidt, M.D., chief of bariatric surgery and ...